feed,title,long_url,short_url
Benzinga,Viatris Stock Gains After FDA Approves Viatris-Biocon Biologics' Insulin Glargine Biosimilar Injection,https://benzinga.com/general/biotech/21/07/22219601/viatris-stock-gains-after-fda-approves-viatris-biocon-biologics-insulin-glargine-biosimilar-injec,https://j.mp/3lgIDfs
Benzinga,Roche's Faricimab US Application For Ocular Diseases Under Priority Review,https://benzinga.com/general/biotech/21/07/22216338/roches-faricimab-us-application-for-ocular-diseases-under-priority-review,https://j.mp/3j0DXb1
Benzinga,Baxter Q2 Earnings Marginally Beat Estimates; Revises Upper End Of 2021 EPS Outlook,https://benzinga.com/news/earnings/21/07/22219190/baxter-q2-earnings-marginally-beat-estimates-revises-upper-end-of-2021-eps-outlook,https://j.mp/3BTYTsP
